代谢学和药物代谢学:在药物发现和开发中推进精准医学
Eleni V Stolaki1,2, Konstantina Psatha1,2,3, Michalis Aivaliotis1,2,4
1Laboratory of Biochemistry, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, GR-54124 Thessaloniki, Greece.
Metabolites
|November 26, 2025
概括
代谢学和药物代谢学是精准医学的关键,有助于药物发现和减少临床试验失败. 这些强大的工具提高了药物安全性,疗效和个性化治疗策略.
科学领域:
- 生物医学科学 生物医学科学
- 药理学 药理学是指药理学的学科.
- 分析化学 分析化学
背景情况:
- 代谢学和药物代谢学对精准医学至关重要,解决了诸如高临床试验失败率和可变药物反应等挑战.
- 这些领域为药物发现和开发提供了强大的工具,通过使全面的代谢组概况成为可能.
研究的目的:
- 突出代谢学在推进精准医学中的关键作用.
- 为新兴科学家提供关于这个复杂领域的见解.
- 讨论分析技术及其克服当前挑战的潜力.
主要方法:
- 关键分析技术的审查:质谱学 (MS) 和核磁共振 (NMR) 光谱学用于代谢物识别,量化和结构阐明.
- 探索分析分离技术:液体染色学 (LC),气体染色学 (GC),离子流动性光谱学 (IMS),毛细电泳 (CE) 和超临界流体染色学 (SFC) 以提高代谢组覆盖率和效率.
- 讨论用于数据分析和生物标志物验证的仪器仪表和计算工具方面的进展.
主要成果:
- 代谢学能够阐明疾病机制,识别药物点,并优化治疗策略.
- 分析技术和分离技术正在不断提高代谢覆盖范围,分析效率和成本效益.
- 持续的进步正在克服代谢组复杂性,数据集成和生物标志物验证方面的挑战.
结论:
- 代谢药和药物代谢药显著提升了精准医学,药物发现和临床试验的成功.
- 这些领域在临床前和临床研究中具有广泛的应用,促进了个性化医疗.
- 分析和计算工具的持续发展将进一步扩大代谢学的翻译潜力.
相关概念视频
01:20Measurement of Bioavailability: Pharmacodynamic Methods
221
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
221
01:14Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
199
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
199
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
162
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
162
01:12Analysis of Population Pharmacokinetic Data
659
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
659
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
179
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
179
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
166
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
166